Market Research Logo

Musculoskeletal Drugs Market Global Briefing 2017Including: Drugs For Rheumatoid Arthritis, Muscle Relaxants, Others.Covering: F. Hoffmann-La Roche Ltd., GlaxosmithKline Plc., Pfizer Inc., Daiichi Sankyo Company, Limited, Abbott Laboratories Inc., Johnson

Musculoskeletal Drugs Market Global Briefing 2017Including: Drugs For Rheumatoid Arthritis, Muscle Relaxants, Others.Covering: F. Hoffmann-La Roche Ltd., GlaxosmithKline Plc., Pfizer Inc., Daiichi Sankyo Company, Limited, Abbott Laboratories Inc., Johnson & Johnson, Sanofi S.A., Novartis AG, Otsuka Pharmaceutical Co., Ltd., Celgene Corporation

The global musculoskeletal drugs market is expected to reach over $165 billion in 2020. This can be attributed to the expected increase in healthcare awareness, number of surgical operations and prevalence of musculoskeletal disorders such as fibromyalgia, rheumatoid arthritis, osteoarthritis around the world. Also, increasing number of road accidents and workplace injuries are expected to contribute to market growth.

Musculoskeletal Drugs Market Global Briefing provides strategists, marketers and senior management with the critical information they need to assess the global musculoskeletal drugs sector.

Reasons to Purchase

  • Get up to date information available on the musculoskeletal drugs market globally.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.
Description

Musculoskeletal Drugs Market Global Briefing from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the musculoskeletal drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the musculoskeletal drugs market and suggests approaches.

Scope

Markets Covered: Drugs For Rheumatoid Arthritis, Muscle Relaxants, Others.
Companies Mentioned: F. Hoffmann-La Roche Ltd., GlaxosmithKline Plc., Pfizer Inc., Daiichi Sankyo Company Limited, Abbott Laboratories Inc., Johnson & Johnson, Sanofi S.A., Novartis AG, Otsuka Pharmaceutical Co., Ltd., Celgene Corporation
Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


Musculoskeletal Drugs Market Characteristics
Musculoskeletal Drugs Market Historic Growth
Musculoskeletal Drugs Market Forecast Growth
Musculoskeletal Drugs Market Segmentation
Global Musculoskeletal Drugs Market, Split By Segments, 2016, $ Billion
Drugs for Rheumatoid Arthritis
Muscle Relaxants
Others
Global Musculoskeletal Drugs Market, Historic and Forecast, Split By Segments, 2012-2020
Musculoskeletal Drugs Market Geography Regional and Country Comparison
Global Musculoskeletal Drugs Market, Split By Regions, 2016
Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020
Global Musculoskeletal Drugs Market, Split By Country, 2016
Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020
Musculoskeletal Drugs Market Competitive Landscape
F. Hoffmann-La Roche Ltd.
Pfizer Inc.
GlaxosmithKline Plc.
Daiichi Sankyo Company, Limited
Abbott Laboratories Inc.
Johnson & Johnson
Sanofi S.A.
Novartis AG
Otsuka Pharmaceutical Co., Ltd.
Celgene Corporation
F.Hoffmann-La Roche
GlaxoSmithKline
Pfizer
Musculoskeletal Drugs Market Key Mergers And Acquisitions
AbbVie Acquired Pharmacyclics
Valeant Acquired Salix Pharmaceuticals
Roche Acquired Adheron Therapeutics
Musculoskeletal Drugs Market Trends And Strategies
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) For Acute Musculoskeletal Pain
New Drug Delivery Technologies
Use of Muscle Relaxants in New Indications
Appendix
NAICS Definitions Of Industry Covered In This Report
Definition Of Market Covered In This Report
Abbreviations
Currencies
Research Methodology
Research Inquiries
The Business Research Company
List of Figures
Figure 1: Global Musculoskeletal Drugs Market, Historic Market Size, 2012-2016, $ Billion
Figure 2: Global Musculoskeletal Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion
Figure 3: Global Musculoskeletal Drugs Market, Split By Segments, 2016, $ Billion
Figure 4: Global Musculoskeletal Drugs Market, Historic and Forecast, Split By Segment, 2012 – 2020
Figure 5: Global Musculoskeletal Drugs Market, Split By Region, 2016, $ Billion
Figure 6: Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020
Figure 7: Global Musculoskeletal Drugs Market, Split By Country, 2016, $ Billion
Figure 8: Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020
Figure 9: Global Musculoskeletal Drugs Market, Key Competitor Market Shares, 2016, Percentage (%)
List of Tables
Table 1: Global Musculoskeletal Drugs Market, Historic Market Size, 2012-2016, $ Billion
Table 2: Global Musculoskeletal Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion
Table 3: Global Musculoskeletal Drugs Market, Split By Segments, 2016, $ Billion
Table 4: Global Musculoskeletal Drugs Market, Historic and Forecast, Split By Segment, 2012 – 2020
Table 5: Global Musculoskeletal Drugs Market, Split By Region, 2016, $ Billion
Table 6: Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020
Table 7: Global Musculoskeletal Drugs Market, Split By Country, 2016, $ Billion
Table 8: Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020
Table 9: Global Musculoskeletal Drugs Market, Key Competitor Market Shares, 2016, Percentage (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report